ETF Holdings Breakdown of NTLA

Stock NameIntellia Therapeutics Inc
TickerNTLA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45826J1051
LEI5493002T5BCPE5DZC723

News associated with NTLA

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Sold by Mariner LLC
Mariner LLC decreased its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 14.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 14,820 shares of the company’s stock after selling 2,496 shares during the quarter. Mariner LLC’s holdings in Intellia Therapeutics were worth […] - 2025-05-08 07:38:44
Dimensional Fund Advisors LP Purchases 528,962 Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Dimensional Fund Advisors LP increased its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 36.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,976,212 shares of the company’s stock after purchasing an additional 528,962 shares during the quarter. […] - 2025-05-07 08:26:54
MetLife Investment Management LLC Buys 3,491 Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA)
MetLife Investment Management LLC boosted its stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 6.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 59,187 shares of the company’s stock after purchasing an additional 3,491 shares during the period. […] - 2025-05-05 08:22:56
Renaissance Technologies LLC Makes New $1.15 Million Investment in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Renaissance Technologies LLC acquired a new position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 98,700 shares of the company’s stock, valued at approximately $1,151,000. Several other institutional investors have also recently […] - 2025-04-30 08:40:57
Marshall Wace LLP Makes New Investment in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Marshall Wace LLP purchased a new stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 95,339 shares of the company’s stock, valued at approximately $1,112,000. Several other large investors also recently made […] - 2025-04-30 07:59:02
Barclays PLC Has $3.63 Million Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Barclays PLC boosted its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 6.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 311,632 shares of the company’s stock after buying an additional 18,837 shares during the period. Barclays PLC owned approximately 0.31% […] - 2025-04-29 08:19:03
Sterling Capital Management LLC Raises Stock Holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Sterling Capital Management LLC lifted its holdings in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 866.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,198 shares of the company’s stock after acquiring an additional 2,867 shares […] - 2025-04-25 08:34:52
Wells Fargo & Company MN Increases Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Wells Fargo & Company MN increased its stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 38.3% in the fourth quarter, HoldingsChannel reports. The firm owned 277,692 shares of the company’s stock after buying an additional 76,872 shares during the period. Wells Fargo & Company MN’s holdings in Intellia Therapeutics were worth […] - 2025-04-23 07:34:49
XTX Topco Ltd Increases Stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
XTX Topco Ltd grew its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 194.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 43,908 shares of the company’s stock after acquiring an additional 29,006 shares during the period. XTX Topco Ltd’s holdings in […] - 2025-04-21 09:10:48
Rockefeller Capital Management L.P. Increases Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Rockefeller Capital Management L.P. boosted its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 81.3% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 137,838 shares of the company’s stock after acquiring an additional 61,800 shares during the period. Rockefeller Capital Management L.P.’s holdings in Intellia […] - 2025-04-21 08:26:43
Schroder Investment Management Group Has $274,000 Stock Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Schroder Investment Management Group lessened its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 72.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 24,000 shares of the company’s stock after selling 61,999 shares during the quarter. Schroder Investment Management […] - 2025-04-09 08:12:51
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Acquired by Mitsubishi UFJ Asset Management Co. Ltd.
Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 67.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,293 shares of the company’s stock after acquiring an additional 6,972 shares during the quarter. Mitsubishi […] - 2025-04-04 08:12:58
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Sold by HighTower Advisors LLC
HighTower Advisors LLC lowered its stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 22.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 15,639 shares of the company’s stock after selling 4,639 shares during the quarter. HighTower Advisors LLC’s holdings in Intellia Therapeutics were worth $182,000 at the end of the most recent […] - 2025-04-04 07:24:50
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Purchased by Intech Investment Management LLC
Intech Investment Management LLC increased its stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 22.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 34,544 shares of the company’s stock after buying an additional 6,341 shares during the quarter. Intech […] - 2025-03-26 08:20:51
Amundi Trims Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Amundi decreased its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 19.7% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 48,795 shares of the company’s stock after selling 11,987 shares during the quarter. Amundi’s holdings in Intellia Therapeutics were worth $587,000 at the end of the most recent quarter. […] - 2025-03-21 07:53:05
Bank of New York Mellon Corp Cuts Stock Holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Bank of New York Mellon Corp reduced its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 1.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 284,614 shares of the company’s stock after selling 3,730 shares […] - 2025-03-20 07:13:00
Wealthfront Advisers LLC Acquires New Shares in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Wealthfront Advisers LLC acquired a new stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 22,525 shares of the company’s stock, valued at approximately $263,000. Other large investors have also recently added to or […] - 2025-03-18 08:25:03
Daiwa Securities Group Inc. Boosts Stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Daiwa Securities Group Inc. grew its stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 80.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,151 shares of the company’s stock after buying an additional 2,299 shares during the quarter. […] - 2025-03-18 07:43:01
Intellia Therapeutics (NASDAQ:NTLA) Price Target Cut to $50.00 by Analysts at Truist Financial
Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) had its price objective dropped by equities researchers at Truist Financial from $90.00 to $50.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Truist Financial’s price objective would indicate a potential upside of 434.19% from the company’s previous close. […] - 2025-03-06 08:37:46
Intellia Therapeutics (NASDAQ:NTLA) Sets New 12-Month Low After Analyst Downgrade
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report)’s share price hit a new 52-week low during trading on Tuesday after Truist Financial lowered their price target on the stock from $90.00 to $50.00. Truist Financial currently has a buy rating on the stock. Intellia Therapeutics traded as low as $8.36 and last traded at $8.58, […] - 2025-03-06 06:29:12
Y Intercept Hong Kong Ltd Makes New $304,000 Investment in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Y Intercept Hong Kong Ltd acquired a new stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 26,071 shares of the company’s stock, valued at approximately $304,000. Several other hedge funds and […] - 2025-03-05 10:19:00
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Bought by Handelsbanken Fonder AB
Handelsbanken Fonder AB lifted its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 7.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 34,700 shares of the company’s stock after acquiring an additional 2,300 shares during the period. Handelsbanken Fonder […] - 2025-03-03 09:35:19
D.A. Davidson & CO. Lowers Stock Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
D.A. Davidson & CO. decreased its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 9.1% in the 4th quarter, Holdings Channel reports. The firm owned 14,770 shares of the company’s stock after selling 1,480 shares during the period. D.A. Davidson & CO.’s holdings in Intellia Therapeutics were worth $172,000 as of its most […] - 2025-02-28 08:46:50
Brokerages Set Intellia Therapeutics, Inc. (NASDAQ:NTLA) Price Target at $48.71
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eighteen ratings firms that are presently covering the company, MarketBeat.com reports. Six analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to […] - 2025-02-27 06:09:05

NTLA institutional holdings

The following institutional investment holdings of NTLA have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 66,172USD 547,904
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 102,746USD 850,737 12.0%
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 48,479USD 401,406
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 48,479USD 401,406 12.0%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 3,865USD 32,002
Total =269,741 USD 2,233,455
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.